(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLINUVEL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLINUVEL

ST13

US500000079219190

Class

3, 5

Filing

79219190

Registration

5563153

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

03/04/2026

Trademark type

Word

Nice classes

3, 5

Filing date

05/11/2017

Registration date

09/18/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/03/2025

Last transaction

03/04/2026

Responsible office

United States Patent and Trademark Office

Status code

708

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

AU

Examiner

SNABB, SANDRA MARIE

Current location

Historical data usage

Holders and representatives

Holders

Clinuvel Pharmaceuticals Limited
Clinuvel Pharmaceuticals Limited

Representatives

Keith A. Weltsch Scully, Scott, Murphy & Presser, P.C.

Technical classification

Nice Classes

Class 3Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Non-medicated skin care preparations; non-medicated skin care preparationscosmetics and cosmetic preparations for skin carecosmetic preparations for skin carebased on analogues of melanocyte stimulating hormonein particular afamelanotidecosmetic nourishing creamsskin cleansing creamsskin lotions for cosmetic purposescosmetic sun protecting preparationscosmetic preparations against sunburncosmetic sun protecting lotionscosmetic sunscreen preparationscosmetics for tanning the skin including preparations for tanning without sunlightbased on analoguesof melanocyte stimulating hormonein particular afamelanotideself-tanning preparationssuntan creamscosmetic suntan lotionscosmetic sun milk lotions; non-medicated skin rejuvenation preparationscreamslotions and cosmetic oils; non-medicated skin rejuvenation productscreamslotions and cosmetic oils with and without analogues of alpha-melanocyte stimulating hormone; anti-aging skin care preparationscreamslotions and cosmetic oils; anti-aging moisturizers used as cosmeticsnon-medicated anti-aging serum; preparations for tanning the skin including preparations for tanning without sunlight

Class 5

Pharmaceuticals and pharmaceutical preparations for the treatment of skin disorders; pharmaceuticals and pharmaceutical preparations for the treatment of skin disordersbased on analogues of melanocyte stimulating hormonein particular afamelanotide pharmaceuticals and pharmaceutical preparations for the treatment of damaged skin and tissue; pharmaceuticals and pharmaceutical preparations for the treatment of sunburn; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for skin care; medicated skin care preparations; medicated sun tanning preparations; medicated sun tanning preparations for pharmaceutical purposesbased on analogues of melanocyte stimulating hormonein particular afamelanotide; diagnostic preparations for medical purposes; chemical and biological preparationssubstancesreagents and compoundspharmaceutical preparations for use in dermatologyfor skin carefor the treatment of skin disordersfor the protection of the dermis and epidermisall used in the manufacturedelivery and storage of pharmaceuticalsdrugs and diagnostic preparations ; vaccines; chemical reagents comprised of polyvalent compounds and synthetic moleculesfor medical and veterinary purposes

Publications

History of USPTO decisions and trademark events.

35 publications found

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/03/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/18/2025

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

07/03/2025

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

07/03/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/30/2025

ES75

TEAS SECTION 71 & 15 RECEIVED

03/15/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

09/18/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/17/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/29/2018

FIMP

FINAL DISPOSITION PROCESSED

12/29/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/18/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

09/18/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/03/2018

PUBO

PUBLISHED FOR OPPOSITION

07/03/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/13/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/25/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

05/25/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/25/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

05/25/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/25/2018

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/21/2018

GNFR

FINAL REFUSAL E-MAILED

05/21/2018

CNFR

FINAL REFUSAL WRITTEN

05/21/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/30/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/27/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/27/2018

RFNT

REFUSAL PROCESSED BY IB

12/01/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/09/2017

RFRR

REFUSAL PROCESSED BY MPU

11/09/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/02/2017

CNRT

NON-FINAL ACTION WRITTEN

11/01/2017

MAFR

APPLICATION FILING RECEIPT MAILED

10/31/2017

DOCK

ASSIGNED TO EXAMINER

10/26/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/26/2017

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

10/19/2017

Continuous trademark protection

Get notified about every new filing that threatens CLINUVEL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.